Arrow Generics launches Atorvastatin Tablets upon patent expiry
Arrow Generics, a Watson Company, are very proud to announce the launch of Atorvastatin Tablets on day 1 of patent expiry.
Read moreArrow Generics, a Watson Company, launches Candesartan Tablets upon patent expiry
Arrow Generics, a Watson Company are very proud to announce the launch of Candesartan Tablets on day 1 of patent expiry. Candesartan is available in strengths of 2mg, 4mg, 8mg, 16mg and 32mg.Read more
Watson Pharmaceuticals and Actavis Group Combining Strengths
The combination will create the world’s number 3 generics company; a stronger and more innovative company.Read more
Arrow Generics launches Quetiapine Tablets
Arrow Generics, a Watson Company, are proud to announce the launch of Quetiapine Tablets on day 1 of patent expiry.
Read moreArrow Generics launches Zolmitriptan Tablets
Arrow Generics, a Watson Company are very proud to announce the launch of Zolmitriptan 2.5mg Film-Coated Tablets and Zolmitriptan 2.5mg and 5mg Orodispersible Tablet
Read moreArrow Generics launches Naratriptan Tablets
Arrow Generics, a Watson Company, launches Naratriptan Tablets, the second day 1 launch in a week!Read more
Arrow Generics UK, a Watson Company
On December 2, 2009, the Arrow Group was acquired by Watson Pharmaceuticals, Inc. a leading U.S. based specialty pharmaceutical company with over $3 billion in annual revenues.
Read moreArrow and Watson, a winning formula
We are a global pharmaceutical company with operations in many of the world's established and growing markets, and a strong product portfolio and pipeline.
Read more
